CoChat

The Interplay between Mitochondrial Morphology and Myomitokines in Aging Sarcopenia

Open access
Romanello, Vanina · 2020 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 130 of the 131 references it cites were found in a registry or an index.

Abstract

Sarcopenia is a chronic disease characterized by the progressive loss of skeletal muscle mass, force, and function during aging. It is an emerging public problem associated with poor quality of life, disability, frailty, and high mortality. A decline in mitochondria quality control pathways constitutes a major mechanism driving aging sarcopenia, causing abnormal organelle accumulation over a lifetime. The resulting mitochondrial dysfunction in sarcopenic muscles feedbacks systemically by releasing the myomitokines fibroblast growth factor 21 (FGF21) and growth and differentiation factor 15 (GDF15), influencing the whole-body homeostasis and dictating healthy or unhealthy aging. This review describes the principal pathways controlling mitochondrial quality, many of which are potential therapeutic targets against muscle aging, and the connection between mitochondrial dysfunction and the myomitokines FGF21 and GDF15 in the pathogenesis of aging sarcopenia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22010091

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mitochondria quality control pathways maintain mitochondrial function. Mitofusin 1 and 2 (MFN1/2) and optic atrophy protein 1 (OPA1) mediate mitochondrial fusion to produce an interconnected healthy mitochondrial network. Mitochondrial fission depends on dynamin-related protein 1 (DRP1) and mitochondrial fission factor (MFF) proteins. Fragmented dysfunctional mitochondria are removed by mitophagy. Bcl2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) and NIP3-like-proteinX (NIX) are mitophagy receptors that bind to microtubule-associated protein 1 light chain 3 (LC3) to tether mitochondria to the autophagosome. PTEN-induced kinase 1 (PINK1) accumulates on depolarized mitochondria surface, where it phosphorylates ubiquitinated outer mitochondrial membrane (OMM) proteins and Parkin. Parkin will further promote the ubiquitination of the OMM proteins. The p62/SQSTM1 adaptor can recognize the ubiquitinated proteins to initiate mitophagy. U: ubiquitin. Figure was created with BioRender.com
Figure 1 Mitochondria quality control pathways maintain mitochondrial function. Mitofusin 1 and 2 (MFN1/2) and optic atrophy protein 1 (OPA1) mediate mitochondrial fusion to produce an interconnected healthy mitochondrial network. Mitochondrial fission depends on dynamin-related protein 1 (DRP1) and mitochondrial fission factor (MFF) proteins. Fragmented dysfunctional mitochondria are removed by mitophagy. Bcl2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) and NIP3-like-proteinX (NIX) are mitophagy receptors that bind to microtubule-associated protein 1 light chain 3 (LC3) to tether mitochondria to the autophagosome. PTEN-induced kinase 1 (PINK1) accumulates on depolarized mitochondria surface, where it phosphorylates ubiquitinated outer mitochondrial membrane (OMM) proteins and Parkin. Parkin will further promote the ubiquitination of the OMM proteins. The p62/SQSTM1 adaptor can recognize the ubiquitinated proteins to initiate mitophagy. U: ubiquitin. Figure was created with BioRender.comCC BY · PubMed Central
Figure 2 Mitochondria-derived signaling pathways controlling muscle mass and whole-body homeostasis. (Left Panel): Continuous rounds of mitochondrial biogenesis and fusion are balanced by opposing mitochondrial fission processes and mitophagy, leading to increased mitochondrial interconnection, optimal calcium homeostasis, and ATP production. The resulting healthy muscle mitochondrial network is critical to preserve muscle mass and force during aging. An active lifestyle is essential to preserve mitochondria and muscle function, promoting healthy aging. (Right Panel): The decline in mitochondria quality control pathways is a trigger of aging sarcopenia. Unbalanced fusion and fission, together with reducing mitophagy and mitochondrial biogenesis, lead to impaired mitochondrial turnover and the accumulation of dysfunctional mitochondria. Mitochondrial dysfunction in aging sarcopenia is characterized by alterations in calcium homeostasis, increased ROS production, and reduced ATP production. ROS production causes endoplasmic reticulum (ER) stress and activation of unfolded protein response (UPR). UPR induces the ATF4-dependent upregulation of fibroblast growth factor 21 (FGF21) and growth and differentiation factor 15 (GDF15) secreted by the muscle contributing to muscle loss, systemic inflammation, metabolic shift, and senescence. The combination of the resulting muscle loss and weakness and the systemic alterations promote unhealthy aging.
Figure 2 Mitochondria-derived signaling pathways controlling muscle mass and whole-body homeostasis. (Left Panel): Continuous rounds of mitochondrial biogenesis and fusion are balanced by opposing mitochondrial fission processes and mitophagy, leading to increased mitochondrial interconnection, optimal calcium homeostasis, and ATP production. The resulting healthy muscle mitochondrial network is critical to preserve muscle mass and force during aging. An active lifestyle is essential to preserve mitochondria and muscle function, promoting healthy aging. (Right Panel): The decline in mitochondria quality control pathways is a trigger of aging sarcopenia. Unbalanced fusion and fission, together with reducing mitophagy and mitochondrial biogenesis, lead to impaired mitochondrial turnover and the accumulation of dysfunctional mitochondria. Mitochondrial dysfunction in aging sarcopenia is characterized by alterations in calcium homeostasis, increased ROS production, and reduced ATP production. ROS production causes endoplasmic reticulum (ER) stress and activation of unfolded protein response (UPR). UPR induces the ATF4-dependent upregulation of fibroblast growth factor 21 (FGF21) and growth and differentiation factor 15 (GDF15) secreted by the muscle contributing to muscle loss, systemic inflammation, metabolic shift, and senescence. The combination of the resulting muscle loss and weakness and the systemic alterations promote unhealthy aging.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 130 references

Cited by

Items 101–104 of 104

Metadata

Authors
Romanello, V.
Affiliations
University of Padua (IT)
Corresponding author
Romanello, Vanina
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-12-23
Volume
22
Issue
1
Pages
91
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3113715762
Cited by
101
References
131
Citations by year
2026: 14 · 2025: 24 · 2024: 13 · 2023: 19 · 2022: 20 · 2021: 11
FWCI
1.20
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Funders
  • STARS-Consolidator Grant (Promemix)
  • AFM-Telethon (22457)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Keywords
sarcopenia, aging, mitochondrial morphology, mitochondrial quality control, FGF21, GDF15, mitochondrial dysfunction, skeletal muscle, muscle aging, therapeutic target
MeSH terms
Animals, Fibroblast Growth Factors, Humans, Mitochondria, Muscle, Muscle, Skeletal, Growth Differentiation Factor 15, Sarcopenia, Mitochondrial Turnover

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.